Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Monster Beverage
MNST
$93.2B
| $324M | 0.18% |
9,335,046
+2,500,470
| +37% | +$81.6M |
|
127
Target
TGT
$63.7B
| $320M | 0.18% |
2,671,438
-199,454
| -7% | -$22.8M |
|
128
Cognex
CGNX
$10.2B
| $318M | 0.18% |
5,324,125
+200,423
| +4% | +$10.9M |
|
129
Globus Medical
GMED
$10.6B
| $315M | 0.18% |
6,603,845
-166,752
| -2% | -$8.04M |
|
130
Oracle
ORCL
$345B
| $314M | 0.18% |
5,674,494
+205,515
| +4% | +$10.9M |
|
131
Cboe Global Markets
CBOE
$30.2B
| $310M | 0.17% |
3,319,138
+272,365
| +9% | +$26.8M |
|
132
Wabtec
WAB
$50.8B
| $309M | 0.17% |
5,374,429
-1,547,744
| -22% | -$87.7M |
|
133
Constellation Brands
STZ
$22.2B
| $309M | 0.17% |
1,764,008
-323,680
| -16% | -$53.9M |
|
134
lululemon athletica
LULU
$13.4B
| $306M | 0.17% |
982,272
-249,017
| -20% | -$63.7M |
|
135
Waters Corp
WAT
$36.4B
| $305M | 0.17% |
1,693,048
+240,992
| +17% | +$45.5M |
|
136
Teleflex
TFX
$5.8B
| $304M | 0.17% |
834,313
+20,555
| +3% | +$7.1M |
|
137
Micron Technology
MU
$1.02T
| $297M | 0.17% |
5,766,168
-293,139
| -5% | -$13.8M |
|
138
Hershey
HSY
$36.6B
| $296M | 0.17% |
2,281,466
+83,945
| +4% | +$11.3M |
|
139
Match Group
MTCH
$9.05B
| $294M | 0.16% |
2,746,915
+20,676
| +0.8% | +$1.73M |
|
140
Dolby
DLB
$4.85B
| $292M | 0.16% |
4,437,649
+39,870
| +0.9% | +$2.39M |
|
|
MRTX
141
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $291M | 0.16% |
2,550,374
+201,473
| +9% | +$19.5M |
|
142
Estee Lauder
EL
$30.1B
| $290M | 0.16% |
1,539,029
+548,755
| +55% | +$98M |
|
143
Starbucks
SBUX
$118B
| $290M | 0.16% |
3,940,421
+929,426
| +31% | +$69.8M |
|
144
Tyler Technologies
TYL
$13B
| $288M | 0.16% |
831,344
-64,702
| -7% | -$21.7M |
|
|
SEE
145
DELISTED
Sealed Air
SEE
| $288M | 0.16% |
8,754,438
+643,833
| +8% | +$19.3M |
|
|
GBT
146
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $286M | 0.16% |
4,535,253
-18,728
| -0.4% | -$1.28M |
|
147
Corning
GLW
$123B
| $284M | 0.16% |
10,951,343
+2,204,035
| +25% | +$50M |
|
148
Bank of America
BAC
$436B
| $281M | 0.16% |
11,839,124
+2,740,072
| +30% | +$64.7M |
|
149
Euronet Worldwide
EEFT
$3.01B
| $278M | 0.16% |
2,906,241
-325,232
| -10% | -$30M |
|
150
IBM
IBM
$204B
| $276M | 0.15% |
2,389,073
-543,221
| -19% | -$63.1M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.